Pfizer: Infections trials

The registry lists 26 Infections studies with Pfizer as lead sponsor. 2 are open to participants now and 10 have results posted.

Phase 1 6Phase 2 1Phase 3 6Phase 4 2No phase 11(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely ImmunocompromisedRecruitingNCT07013474Phase 3
• A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe DiseaseRecruitingNCT06679140Phase 3
• RITUXIMAB BS Intravenous Infusion 100mg・500mg [Pfizer] Post-marketing Database StudyCompletedNCT06790420Results posted
• Pharmacokinetic Study of Aztreonam-Avibactam in Severe Renal ImpairmentCompletedNCT04486625Phase 1Results posted
• Real-World Observational Study Of Zavicefta to Characterize Use PatternsCompletedNCT03923426Results posted
• Tygacil Drug Use InvestigationCompletedNCT01789905Results posted
• Study Evaluating The Safety And Effectiveness In Subjects With Tigecycline TreatmentCompletedNCT01072539Results posted
• Study of Count Coughs in Subjects With Acute Upper Respiratory Tract InfectionsCompletedNCT01062256Not applicableResults posted
• Study Evaluating The Efficacy Of A Novel Ibuprofen Formulation On Fever In Patients With An Uncomplicated Acute InfectionTerminatedNCT01035346Phase 3Results posted
• Post-Marketing Study Of The Safety Of Tygacil (Tigecycline)CompletedNCT00683332Results posted
• A Pharmacovigilance Evaluation And Assessment Of The Prescribing Practice For Tygacil In Usual Health Care SettingCompletedNCT00488488Results posted
• Dalteparin vs Unfractionated Heparin For The Prevention Of Venous Thromboembolism (VTE) In Hospitalized Acutely Ill Medical PatientsTerminatedNCT00445328Phase 4Results posted
• A Study of How Ibuzatrelvir is Taken up Into the Blood of Healthy Adults After Taking Different Tablets of IbuzatrelvirCompletedNCT07552779Phase 1
• A Study to Learn About the Medicine Called Nirmatrelvir Used in Combination With Ritonavir in People With Weakened Immune Systems or at Increased Risk for Poor Outcomes Who Are Hospitalized Due to Severe COVID-19WithdrawnNCT05545319Phase 2
• Study Evaluating Tigecycline Versus Ceftriaxone In Complicated Intra-Abdominal Infections & Community Acquired PneumoniaWithdrawnNCT01602874Phase 3
• A Study To Assess The Safety, Tolerability And Pharmacokinetics Of Metronidazole Injection In Healthy Japanese SubjectsCompletedNCT01407016Phase 1
• Study Evaluating Local Susceptibility Patterns Associated With Tigecycline in Comparison to Other AntibioticsCompletedNCT01311349
• Safety, Pharmacokinetics (PK) and Tolerability Study of a Novel Drug for Treatment of Bacterial InfectionsCompletedNCT01015014Phase 1
• Study Evaluating Tigecycline Versus Ceftriaxone In Complicated Intra-Abdominal Infections & Community Acquired PneumoniaWithdrawnNCT00914888Phase 3
• Study Evaluating Tigecycline Versus Clindamycin Or Vancomycin On Complicated Skin And Skin Structure Infections Including Those Due To Methicillin-Resistant Staphylococcus Aureus (MRSA) In Pediatric SubjectsWithdrawnNCT00911573Phase 3
• Epidemiologic Study Evaluating Infections in Elderly PatientsCompletedNCT00900952
• Study Evaluating The Excretion Of Moxidectin Into The Breast Milk Of Lactating, Non-Breastfeeding WomenCompletedNCT00751764Phase 1
• Study Evaluating The Effect Of High-Fat Meal On Bioavailability And Pharmacokinetics Of Single Dose Of MoxidectinCompletedNCT00736697Phase 1
• Assessing Prevalence Of Beta Lactamase Production From Clinical Isolates Of Hospitalized Patients And Comparison Of Antibiotic Susceptibility PatternsCompletedNCT00728624
• A Post-Intervention Surveillance Study Regarding the Acquisition Rate of ESBL-KP, EcoliCompletedNCT00724919
• A Comparative Phase IV Study Evaluating Efficacy & Safety Of Magnex(Cefoperazone-Sulbactam) In Intraabdominal InfectionsCompletedNCT00360607Phase 4